{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:22:41Z","timestamp":1793038961741,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.esmorw.2025.100662","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:28:26Z","timestamp":1767716906000},"page":"100662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"T.","family":"Ruelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-9627","authenticated-orcid":false,"given":"T.","family":"Grinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-5841","authenticated-orcid":false,"given":"L.","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-8536","authenticated-orcid":false,"given":"M.","family":"Lacroix-Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-7199","authenticated-orcid":false,"given":"B.","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-0339","authenticated-orcid":false,"given":"G.","family":"Gessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.esmorw.2025.100662_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00428-020-02894-6","article-title":"Number of pathologists in Germany: comparison with European countries, USA, and Canada","volume":"478","author":"M\u00e4rkl","year":"2021","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.esmorw.2025.100662_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253876","article-title":"Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports","volume":"16","author":"Bonert","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.esmorw.2025.100662_bib4","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.3390\/jcm9113697","article-title":"Digital pathology: advantages, limitations and emerging perspectives","volume":"9","author":"Jahn","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.esmorw.2025.100662_bib5","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s00330-021-07892-z","article-title":"Artificial intelligence in radiology: 100 commercially available products and their scientific evidence","volume":"31","author":"Van Leeuwen","year":"2021","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","article-title":"Artificial intelligence in histopathology: enhancing cancer research and clinical oncology","volume":"3","author":"Shmatko","year":"2022","journal-title":"Nat Cancer"},{"issue":"7","key":"10.1016\/j.esmorw.2025.100662_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.annonc.2025.03.006","article-title":"Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives","volume":"36","author":"Marra","year":"2025","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/modpathol.2013.134","article-title":"The estimation of tumor cell percentage for molecular testing by pathologists is not accurate","volume":"27","author":"Smits","year":"2014","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.esmorw.2025.100662_bib9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41379-022-01161-0","article-title":"Artificial intelligence-augmented histopathologic review using image analysis to optimize DNA yield from formalin-fixed paraffin-embedded slides","volume":"35","author":"Osinski","year":"2022","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.esmorw.2025.100662_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ajpath.2025.01.009","article-title":"Tumor cellularity assessment using artificial intelligence trained on immunohistochemistry-restained slides improves selection of lung adenocarcinoma samples for molecular testing","volume":"195","author":"Gertych","year":"2025","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep46450","article-title":"Accurate and reproducible invasive breast cancer detection in whole-slide images: a deep learning approach for quantifying tumor extent","volume":"7","author":"Cruz-Roa","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.esmorw.2025.100662_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JMI.4.4.044504","article-title":"Context-aware stacked convolutional neural networks for classification of breast carcinomas in whole-slide histopathology images","volume":"4","author":"Bejnordi","year":"2017","journal-title":"J Med Imaging"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41523-022-00496-w","article-title":"Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies","volume":"8","author":"Sandbank","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"22","key":"10.1016\/j.esmorw.2025.100662_bib14","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2017.14585","article-title":"Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer","volume":"318","author":"Ehteshami Bejnordi","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.esmorw.2025.100662_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100216","article-title":"Artificial intelligence-aided diagnosis of breast cancer lymph node metastasis on histologic slides in a digital workflow","volume":"36","author":"Challa","year":"2023","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.esmorw.2025.100662_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/PAS.0000000000002248","article-title":"Artificial intelligence helps pathologists increase diagnostic accuracy and efficiency in the detection of breast cancer lymph node metastases","volume":"48","author":"Retamero","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.esmorw.2025.100662_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2607","article-title":"Breast cancer prognostic classification in the molecular era: the role of histological grade","volume":"12","author":"Rakha","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/modpathol.3800161","article-title":"Prognostic relevance of histological grade and its components in node-negative breast cancer patients","volume":"17","author":"Volpi","year":"2004","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13000-020-00995-z","article-title":"Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses","volume":"15","author":"Pantanowitz","year":"2020","journal-title":"Diagn Pathol"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/diagnostics15091127","article-title":"Evaluating AI-based mitosis detection for breast carcinoma in digital pathology: a clinical study on routine practice integration","volume":"15","author":"Simmat","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13058-025-02019-4","article-title":"Predicting Nottingham grade in breast cancer digital pathology using a foundation model","volume":"27","author":"Kim","year":"2025","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41523-022-00478-y","article-title":"Deep learning models for histologic grading of breast cancer and association with disease prognosis","volume":"8","author":"Jaroensri","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"10.1016\/j.esmorw.2025.100662_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group","volume":"113","author":"Nielsen","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-024-07352-4","article-title":"The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer","volume":"207","author":"Rewcastle","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212309","article-title":"Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment","volume":"14","author":"Kwon","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/his.15294","article-title":"Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms","volume":"86","author":"Zwager","year":"2025","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.esmorw.2025.100662_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00000478-200207000-00005","article-title":"Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists","volume":"26","author":"R\u00fcdiger","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/PAI.0000000000000502","article-title":"Virtual double staining: a digital approach to immunohistochemical quantification of estrogen receptor protein in breast carcinoma specimens","volume":"26","author":"Lykkegaard Andersen","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9736-z","article-title":"Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases","volume":"110","author":"Turbin","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100033","article-title":"Noninferiority of artificial intelligence\u2013assisted analysis of Ki-67 and estrogen\/progesterone receptor in breast cancer routine diagnostics","volume":"36","author":"Abele","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.esmorw.2025.100662_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpi.2022.100122","article-title":"Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use","volume":"13","author":"Shafi","year":"2022","journal-title":"J Pathol Inform"},{"issue":"20","key":"10.1016\/j.esmorw.2025.100662_bib32","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmorw.2025.100662_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/modpathol.2017.171","article-title":"Clinical relevance and concordance of HER2 status in local and central testing\u2014an analysis of 1581 HER2-positive breast carcinomas over 12 years","volume":"31","author":"Pfitzner","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.esmorw.2025.100662_bib35","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","article-title":"Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer","volume":"391","author":"Bardia","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.esmorw.2025.100662_bib36","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41591-024-03021-7","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial","volume":"30","author":"Cort\u00e9s","year":"2024","journal-title":"Nat Med"},{"issue":"10390","key":"10.1016\/j.esmorw.2025.100662_bib37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)00725-0","article-title":"Trastuzumab deruxtecan versus treatment of physician\u2019s choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial","volume":"401","author":"Andr\u00e9","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.esmorw.2025.100662_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105818","article-title":"Best pathology practices for HER2 testing interpretation, including HER2-low and ultralow, in the era of HER2-directed antibody drug conjugates (ADCs), aligned with the 2018 CAP\/ASCO HER2 guidelines","volume":"162","author":"Marabi","year":"2025","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep45938","article-title":"Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer","volume":"7","author":"Vandenberghe","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/his.15274","article-title":"Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low cases","volume":"85","author":"Bannier","year":"2024","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.esmorw.2025.100662_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/PO.24.00353","article-title":"Fully automated artificial intelligence solution for human epidermal growth factor receptor 2 immunohistochemistry scoring in breast cancer: a multireader study","author":"Krishnamurthy","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.esmorw.2025.100662_bib43","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmorw.2025.100662_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.breast.2021.11.003","article-title":"Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer","volume":"60","author":"Noske","year":"2021","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.esmorw.2025.100662_bib45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/PAS.0000000000001701","article-title":"SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 and 22C3","volume":"45","author":"Pang","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41379-021-00904-9","article-title":"Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer","volume":"35","author":"Wu","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41523-021-00268-y","article-title":"How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies","volume":"7","author":"Wang","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100662_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/his.15205","article-title":"Artificial intelligence enhances whole-slide interpretation of PD-L1 CPS in triple-negative breast cancer: a multi-institutional ring study","volume":"85","author":"Li","year":"2024","journal-title":"Histopathology"},{"issue":"13","key":"10.1016\/j.esmorw.2025.100662_bib49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9938","key":"10.1016\/j.esmorw.2025.100662_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib51","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41598-022-13917-4","article-title":"Quantitative digital histopathology and machine learning to predict pathological complete response to chemotherapy in breast cancer patients using pre-treatment tumor biopsies","volume":"12","author":"Saednia","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10549-020-06093-4","article-title":"Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients","volume":"186","author":"Dodington","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41591-022-02155-w","article-title":"Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer","volume":"29","author":"Du Terrail","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12967-021-03020-z","article-title":"Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer","volume":"19","author":"Li","year":"2021","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41379-021-00911-w","article-title":"Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer","volume":"35","author":"Farahmand","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib56","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/s41598-021-83102-6","article-title":"Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy","volume":"11","author":"Bychkov","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.esmorw.2025.100662_bib57","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.7150\/ijbs.55453","article-title":"Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src\/PI3K\/Akt pathway","volume":"17","author":"Wu","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-025-01959-1","article-title":"Annotation-free deep learning algorithm trained on hematoxylin & eosin images predicts epithelial-to-mesenchymal transition phenotype and endocrine response in estrogen receptor-positive breast cancer","volume":"27","author":"Hu","year":"2025","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48830-x","article-title":"Deep learning-enabled breast cancer endocrine response determination from H&E staining based on ESR1 signaling activity","volume":"13","author":"Ng","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.esmorw.2025.100662_bib60","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.esmorw.2025.100662_bib61","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/modpathol.2008.34","article-title":"Current issues in ER and HER2 testing by IHC in breast cancer","volume":"21","author":"Gown","year":"2008","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib62","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/s41591-025-03780-x","article-title":"Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection","volume":"31","author":"Campanella","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.esmorw.2025.100662_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1593143","article-title":"Predicting estrogen receptor status from HE-stained breast cancer slides using artificial intelligence","volume":"12","author":"H\u00f8ib\u00f8","year":"2025","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41523-018-0079-1","article-title":"Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype","volume":"4","author":"Couture","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"10.1016\/j.esmorw.2025.100662_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.clbc.2025.06.005","article-title":"A deep-learning solution identifies HER2 negative cases and provides ER and PR results from H&E-stained breast cancer specimens: a blind validation study","volume":"25","author":"Walsh","year":"2025","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43856-024-00695-5","article-title":"Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slides","volume":"4","author":"Shamai","year":"2024","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib67","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1038\/s41467-022-34275-9","article-title":"Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer","volume":"13","author":"Shamai","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.esmorw.2025.100662_bib68","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19201","article-title":"Multiple instance learning-based prediction of programmed death-ligand 1 (PD-L1) expression from hematoxylin and eosin (H&E)-stained histopathological images in breast cancer","volume":"13","author":"Da","year":"2025","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.esmorw.2025.100662_bib69","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41379-021-00826-6","article-title":"Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies","volume":"34","author":"Chatrian","year":"2021","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.esmorw.2025.100662_bib70","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s44276-023-00021-x","article-title":"Penetrance estimates of hereditary cancers in a population setting using UK Biobank data","volume":"2","author":"Manchanda","year":"2024","journal-title":"BJC Rep"},{"key":"10.1016\/j.esmorw.2025.100662_bib72","article-title":"Prediction of BRCA gene mutation in breast cancer based on deep learning and histopathology images","volume":"12","author":"Wang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.esmorw.2025.100662_bib73","article-title":"An interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer from hematoxylin and eosin-stained pathological images","volume":"12","author":"Li","year":"2024","journal-title":"PeerJ"},{"issue":"12","key":"10.1016\/j.esmorw.2025.100662_bib74","article-title":"Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images","volume":"3","author":"Lazard","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.esmorw.2025.100662_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115199","article-title":"Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides","volume":"216","author":"Marm\u00e9","year":"2025","journal-title":"Eur J Cancer"},{"issue":"25","key":"10.1016\/j.esmorw.2025.100662_bib76","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.esmorw.2025.100662_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.esmorw.2025.100662_bib78","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.22.00069","article-title":"Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update","volume":"40","author":"Andre","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmorw.2025.100662_bib79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.breast.2019.05.006","article-title":"Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data","volume":"46","author":"Orucevic","year":"2019","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41523-024-00700-z","article-title":"A multi-model approach integrating whole-slide imaging and clinicopathologic features to predict breast cancer recurrence risk","volume":"10","author":"Goyal","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib81","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s41467-025-57283-x","article-title":"Multimodal histopathologic models stratify hormone receptor-positive early breast cancer","volume":"16","author":"Boehm","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.esmorw.2025.100662_bib82","series-title":"Proc. SPIE 12933 Medical Imaging 2024: Digital and Computational Pathology","first-page":"6","article-title":"Deep-ODX: an efficient deep learning tool to risk stratify breast cancer patients from histopathology images","author":"Su","year":"2024"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41698-023-00472-y","article-title":"AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer","volume":"7","author":"Wahab","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13058-024-01879-6","article-title":"Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images","volume":"26","author":"Sharma","year":"2024","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib85","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1038\/s41467-025-60824-z","article-title":"Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides","volume":"16","author":"Garberis","year":"2025","journal-title":"Nat Commun"},{"issue":"28","key":"10.1016\/j.esmorw.2025.100662_bib86","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1200\/JCO-25-00742","article-title":"Identifying patients with low relapse rate despite high-risk estrogen receptor\u2013positive\/human epidermal growth factor receptor 2\u2013negative early breast cancer: development and validation of a clinicopathologic assay","volume":"43","author":"Bidard","year":"2025","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13058-022-01592-2","article-title":"Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years","volume":"24","author":"Fernandez","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"21","key":"10.1016\/j.esmorw.2025.100662_bib88","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/jnci\/djp335","article-title":"Use of archived specimens in evaluation of prognostic and predictive biomarkers","volume":"101","author":"Simon","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.esmorw.2025.100662_bib89","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00428-025-04064-y","article-title":"Implementing digital pathology: qualitative and financial insights from eight leading European laboratories","volume":"487","author":"Matias-Guiu","year":"2025","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.esmorw.2025.100662_bib90","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1038\/s41591-024-03258-2","article-title":"A toolbox for surfacing health equity harms and biases in large language models","volume":"30","author":"Pfohl","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100662_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/jpi.jpi_84_20","article-title":"Artificial intelligence in pathology: from prototype to product","volume":"12","author":"Homeyer","year":"2021","journal-title":"J Pathol Inform"},{"issue":"10","key":"10.1016\/j.esmorw.2025.100662_bib92","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1038\/s41591-025-03953-8","article-title":"The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence","volume":"31","author":"Sounderajah","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.esmorw.2025.100662_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104464","article-title":"Computational pathology for breast cancer: where do we stand for prognostic applications?","volume":"81","author":"Gessain","year":"2025","journal-title":"Breast"},{"issue":"15","key":"10.1016\/j.esmorw.2025.100662_bib94","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1002\/cam4.2548","article-title":"Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists","volume":"8","author":"McNamara","year":"2019","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.esmorw.2025.100662_bib95","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s43018-025-00991-6","article-title":"Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology","volume":"6","author":"Ferber","year":"2025","journal-title":"Nat Cancer"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294982012500551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294982012500551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:23:39Z","timestamp":1774488219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294982012500551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":95,"alternative-id":["S294982012500551X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100662","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100662"}}